Sangamo BioSciences (SGMO) Reports In-Line Q2 Loss of $0.18
Tweet Send to a Friend
Sangamo BioSciences (Nasdaq: SGMO) reports a Q2 loss of $0.18, in-line with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
